Kauff ND - Search Results

1

Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.

Kauff ND, Hurley KE, Hensley ML, Robson ME, Lev G, Goldfrank D, Castiel M, Brown CL, Ostroff JS, Hann LE, Offit K, Barakat RR. Kauff ND, et al. Cancer. 2005 Jul 15;104(2):314-20. doi: 10.1002/cncr.21148. Cancer. 2005. PMID: 15948173 Free article.

2

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Satagopan JM, et al. Among authors: kauff nd. Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589

3

Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.

Kauff ND, Brogi E, Scheuer L, Pathak DR, Borgen PI, Hudis CA, Offit K, Robson ME. Kauff ND, et al. Cancer. 2003 Apr 1;97(7):1601-8. doi: 10.1002/cncr.11225. Cancer. 2003. PMID: 12655515 Free article.

4

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D. Hensley ML, et al. Among authors: kauff nd. Gynecol Oncol. 2003 Jun;89(3):440-6. doi: 10.1016/s0090-8258(03)00147-1. Gynecol Oncol. 2003. PMID: 12798709

5

Hereditary ovarian cancer in Ashkenazi Jews.

Robles-Díaz L, Goldfrank DJ, Kauff ND, Robson M, Offit K. Robles-Díaz L, et al. Among authors: kauff nd. Fam Cancer. 2004;3(3-4):259-64. doi: 10.1007/s10689-004-9552-0. Fam Cancer. 2004. PMID: 15516850 Review.

6

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K. Kauff ND, et al. J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4. doi: 10.1093/jnci/dji281. J Natl Cancer Inst. 2005. PMID: 16174860

7

Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.

Stadler ZK, Saloustros E, Hansen NA, Schluger AE, Kauff ND, Offit K, Robson ME. Stadler ZK, et al. Among authors: kauff nd. Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11. Breast Cancer Res Treat. 2010. PMID: 20221693

8

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.

Stadler ZK, Salo-Mullen E, Patil SM, Pietanza MC, Vijai J, Saloustros E, Hansen NA, Kauff ND, Kurtz RC, Kelsen DP, Offit K, Robson ME. Stadler ZK, et al. Among authors: kauff nd. Cancer. 2012 Jan 15;118(2):493-9. doi: 10.1002/cncr.26191. Epub 2011 May 19. Cancer. 2012. PMID: 21598239 Free article.

9

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.

Hyman DM, Zhou Q, Iasonos A, Grisham RN, Arnold AG, Phillips MF, Bhatia J, Levine DA, Aghajanian C, Offit K, Barakat RR, Spriggs DR, Kauff ND. Hyman DM, et al. Among authors: kauff nd. Cancer. 2012 Aug 1;118(15):3703-9. doi: 10.1002/cncr.26655. Epub 2011 Dec 2. Cancer. 2012. PMID: 22139894 Free PMC article.

10

Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families.

Arnold AG, Otegbeye E, Fleischut MH, Glogowski EA, Siegel B, Boyar SR, Salo-Mullen E, Amoroso K, Sheehan M, Berliner JL, Stadler ZK, Kauff ND, Offit K, Robson ME, Zhang L. Arnold AG, et al. Among authors: kauff nd. Breast Cancer Res Treat. 2014 Jun;145(3):625-34. doi: 10.1007/s10549-014-2987-6. Epub 2014 May 14. Breast Cancer Res Treat. 2014. PMID: 24825132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters